Mometasone Furoate topical and Nevirapine Extended Release

• Generic Name: mometasone topical
• Dosage Forms: n.a.
• Other Brand Names: Elocon

Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Generally most effective in acute or chronic dermatoses (e.g., seborrheic or atopic dermatitis, localized neurodermatitis, anogenital pruritus, psoriasis, late phase of allergic contact dermatitis, inflammatory phase of xerosis).

Topical therapy generally preferred over systemic therapy; fewer associated adverse systemic effects.

Topical therapy generally only controls manifestations of dermatoses; eliminate cause if possible.

Topical efficacy may be increased by using a higher concentration or occlusive dressing therapy. (See Administration with Occlusive Dressing under Dosage and Administration.)

Response may vary from one topical corticosteroid preparation to another.

Anti-inflammatory activity may vary considerably depending on the vehicle, drug concentration, site of application, disease, and individual patient.

Should not be used in the treatment of acne, rosacea, or perioral dermatitis.

• Generic Name: nevirapine
• Dosage Forms: tablet, extended release
• Other Brand Names: Viramune, Viramune XR

Nevirapine is an antiviral medicine that prevents human immunodeficiency virus (HIV) from multiplying in your body.

Nevirapine is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Nevirapine is not a cure for HIV or AIDS, and should not be used to prevent HIV.

Nevirapine oral solution (liquid) is for use in adults and children as young as 15 days old. Nevirapine extended-release tablets are for use in adults and children who are at least 6 years old.

Nevirapine may also be used for purposes not listed in this medication guide.